The ILLUMINA Study. (ILLUMINA)

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT03510676

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
CID - Carbostent & Implantable Devices (from the registry)
Registry
  • NCT NCT03510676
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
France, Germany, Italy (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03510676. Allocation not applicable; no masking; primary purpose treatment. Start 2016-01-26 (actual); primary completion 2018-03-07 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The ILLUMINA Study. (ILLUMINA)
Acronym
ILLUMINA
Condition
Peripheral Arterial Disease
Intervention (Device)
NiTiDES
Lead sponsor
CID - Carbostent & Implantable Devices (class: industry)

Record details

Record id
cardio:ct-nct03510676
Content hash
260e0db3ef6a3db8043e132bd5b91af1f37f000e77f9e31ae575f30be1c8d05c